retatrutide news today recency 3 Today, we shared new data from two Phase trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide Results: 24% Weight Loss

An additional study explored the vitamins, minerals, and nutrients that GLP-1 users typically fall short on, and how these are essential for neurochemical balance and cognitive function

If its cloudy or contains particulates, do not use it

Protein First, Always Your body needs approximately 100-120g of protein daily to preserve muscle mass during weight loss

The diabetes GLP-1 market (for type 2 diabetes treatment) similarly shows continued expansion, partly due to new patients being prescribed these powerful agents

Martn G

By regularly tracking these metrics, you and your healthcare provider can determine how effective the therapy is and tweak your plan if needed